RECEIVE PAID PRE-PROMO STOCK ALERTS FOR FREE: NEW CONCEPT LAUNCHES TODAY FOR MICRO-CAP STOCK TRADERS

Ask any trader, what is the largest problem with trading micro-cap stocks? They will tell you that the largest problem is being caught at the tail end holding the bag!

What is the foremost problem with receiving picks from the best newsletters? Emails are unreliable and never show up on time. We are solving both of these problems for you today.

Our members will get Pre-Promotion VIP Early Alerts from the most effective newsletters in the industry and the best part is they are delivered in real time via our PRIVATE TWITTER FEED: https://twitter.com/ALLVIPALERTS

We pay for Pre-Promotion, VIP and early alert services so you don't have to. Get the pre-promo information in one spot.

Do NOT Hesitate. We are offering this amazing opportunity FREE for 3 months to the first 500 followers.

No Credit Card No Spam No Obligation No Emails

We are focusing on multi-day longer campaigns to maximize the potential for our (ALLVIP) members.

This is a no brainer. We are paying thousands in VIP memberships to bring you the best picks in real time from the top newsletters in the industry. Join Now! Use the link above to become one the first followers to ALLVIPALERTS.

Be ready for what should be our biggest alert of the year. New public company with tiny float. Looking for monster triple digit gains.

Watch list for the Most Traded Stocks in the OTC Market. This is not an alert and we were not compensated for the following watch list.

Elite Pharmaceutical, Inc. (OTCQB: ELTP) is a pharmaceutical company developing a pipeline of pharmacological abuse-deterrent opioid products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. Elite has eight commercial products currently being sold, eleven additional approved products pending manufacturing site transfer and two additional products under review pending approval by the FDA.

ELTP announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg capsules. Isradipine is a calcium channel blocker prescribed for hypertension. Annual U.S. sales for immediate release Isradipine 2.5 mg and 5.0 mg capsules are approximately $5.5 million for the twelve months ending June 30, 2014 according to IMS Health Data.

Fannie Mae (OTCQB: FNMA) is a publicly traded company that was chartered by Congress in 1938 to support liquidity, stability and affordability in the secondary mortgage market, where existing mortgage-related assets are purchased and sold.

Currently FNMA is required to relinquish 100% of its profits to the US Treasury as a consequence of the financial bailout it received. There have been many ongoing lawsuits in an attempt to change that government mandate and return profits to the company.

Amazonas Florestal Ltd. (OTCBB: AZFL) is a natural resources company. The company manages its large tracts of land in the rainforests of Amazonas, Brazil. This land, which has been in the families of management and shareholders for over fifty years, consists of more than 114,108 acres of virgin rainforest and has an appraised value of over US$30 million.

The company expects its Brazilian operations to begin shipping substantially in 2015, capitalizing on recent market price increases in most of the flooring, decking and sleeper products that Amazonas is focused on manufacturing. AZFL says its Hemp subsidiary in Colorado is taking shape and profitable revenue in 2015 seems to be very good probability.

MyECheck, Inc. (OTCBB: MYEC) is an electronic payment technology developer and payment services provider. This patented payment method is a fast, secure and cost effective method of processing payments. It works with the most people, businesses and entities.

MYEC has signed an agreement to acquire 100% of the stock of Seergate, developer of a comprehensive electronic payment software platform for banks, in exchange for a minimum $3 M in shares of MyECheck common stock. The Seergate system will be integrated with the MyECheck payment systems adding multiple new capabilities to MyECheck's payment platform.

The company has increased its authorized share volume from 2.5 billion to 3.5 billion shares. The company, in a letter to shareholders, explains the need for additional shares is related to debt conversion.

ALLVIPALERTS employees are not registered as an Investment Adviser in any jurisdiction whatsoever. This press release is for informational purposes only and is not intended to be a recommendation to buy or sell securities in any of the companies listed here.

Source: ALLVIPALERTS